Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.11 | 0.7 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |